• Tetrandrine Alkaloid: Translational Leverage for Modern Ion

  2026-06-22

  This thought-leadership article examines the mechanistic depth and translational promise of Tetrandrine alkaloid, with actionable guidance for researchers targeting ion channels, inflammation, and disease modeling workflows. By situating Tetrandrine within the competitive landscape and drawing from both literature and APExBIO’s product intelligence, this piece offers a forward-looking perspective on optimizing experimental design, assay reproducibility, and cross-domain applications. The article also addresses the importance and limitations of extending Tetrandrine’s role into emerging research domains, supported by protocol parameters and evidence integration.

• Ceftolozane-Tazobactam in Nosocomial Pneumonia: Innovations,

  2026-06-21

  The referenced study analyzes ceftolozane-tazobactam as an innovative antimicrobial for nosocomial pneumonia, focusing on its molecular structure, resistance stability, and clinical efficacy in multidrug-resistant Pseudomonas aeruginosa. These insights have practical significance for optimizing antibiotic resistance assays and benchmarking new glycopeptide agents against Gram-negative threats.

• Diclofenac in Intestinal Organoids: Applied COX Inhibition W

  2026-06-20

  Diclofenac, a high-purity non-selective COX inhibitor, is powering transformative research in inflammation and pain signaling using advanced human intestinal organoid platforms. This guide translates the latest hiPSC-derived organoid breakthroughs into actionable workflows, troubleshooting insights, and comparative assay strategies for maximizing translational impact.

• Cabozantinib (XL184): Systems-Level Mechanisms & Assay Impli

  2026-06-19

  Explore the systems-level mechanisms of Cabozantinib (XL184) as a multi-kinase inhibitor and discover how chronic exposure shapes assay decisions in RCC research. This article offers unique, actionable insights for scientists utilizing Cabozantinib in advanced experimental models.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-06-19

  The referenced study uncovers how mitogen-activated protein kinase 10 (MAPK10) suppresses metastasis in non-small cell lung cancer (NSCLC) by phosphorylating keratin 16 (KRT16), which triggers its ubiquitination and proteasomal degradation. This mechanistic insight highlights the MAPK10/KRT16/RNF213 axis as a potential prognostic biomarker and therapeutic target, refining our understanding of metastatic regulation and opening new avenues for personalized NSCLC treatment.

• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor in Apoptosis As

  2026-06-18

  Z-LEHD-FMK empowers researchers to dissect mitochondria-mediated apoptosis with precision by selectively and irreversibly targeting caspase-9. This article delivers advanced guidance on experimental workflows, troubleshooting, and emerging applications—bridging recent mechanistic breakthroughs in cell death research with optimized, reproducible assay design.

• Strategic Caspase-3 Inhibition: Z-DEVD-FMK in Translational

  2026-06-18

  This thought-leadership article explores the dual mechanistic and translational value of Z-DEVD-FMK, an irreversible caspase-3 inhibitor, for advancing apoptosis and neuroprotection research. Bridging foundational findings from bystander cell death to actionable experimental workflows, we position Z-DEVD-FMK as a platform molecule for dissecting cell death signaling and optimizing translational models, including traumatic brain injury and toxin-induced lung injury.

• Selective Recovery of Moraxella spp. Using Vancomycin Agar i

  2026-06-17

  Leger's study introduces a vancomycin-based selective medium to improve isolation and characterization of Moraxella species from bovine specimens. This methodological advance reduces contamination and enhances detection, with implications for research into infectious bovine keratoconjunctivitis (IBK) and antibiotic resistance.

• GSH-Responsive MOF Nanoparticles for Melanoma Photothermal-I

  2026-06-17

  This study introduces a modular nanoplatform that integrates indocyanine green and a PD-1 inhibitory peptide within GSH-responsive MOF nanoparticles, enabling synergistic photothermal and immunotherapy against melanoma. The approach demonstrates targeted immune checkpoint blockade and enhanced tumor ablation, advancing multifunctional in vivo imaging and cancer treatment strategies.

• Necrostatin-1: Novel Insights into RIP1 Kinase Inhibition an

  2026-06-16

  Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, enables advanced investigation of necroptosis in metabolic disease models. This article uniquely bridges necroptosis chemistry with adipose tissue biology, offering actionable guidance for research beyond standard inflammation or injury paradigms.

• Targeting NUAK1/2 to Reduce Pathological Tau in Alzheimer’s

  2026-06-16

  Taylor et al. (2024) characterize the pathological significance of tau phosphorylation at Ser356 in Alzheimer’s disease (AD) and demonstrate that selective inhibition of NUAK1/2 with WZ4003 reduces this phospho-tau species in human and mouse brain slice cultures. Their work provides mechanistic evidence linking NUAK kinase activity to tauopathy and offers practical insights for translational neurodegeneration research.

• Mechanisms of Milk Extracellular Vesicle Uptake in Intestina

  2026-06-15

  This study systematically investigates how milk-derived extracellular vesicles (MEV) interact with physiologically relevant intestinal stem cell–based organoid models. The research elucidates region- and polarity-specific uptake mechanisms of MEV and demonstrates their influence on gene expression related to stemness and differentiation, providing new insights for membrane trafficking and endocytosis research.

• Autologous Engineered Esophagus: Functional Integration in P

  2026-06-15

  This study demonstrates the creation and successful functional integration of an autologous, tissue-engineered esophageal graft in a large-animal (minipig) model. The work overcomes previous challenges in muscle regeneration, stent dependence, and long-term function, offering a translational step forward for pediatric esophageal reconstruction.

• Caspase 3/7 Facilitate Autophagy and DNA Repair in Breast Ca

  2026-06-14

  This study uncovers a non-apoptotic, conserved function of caspase 3 and caspase 7 in promoting cytoprotective autophagy and DNA damage response under non-lethal stress in human breast cancer cells. These findings reshape our understanding of stress adaptation mechanisms and suggest new avenues for targeting cancer stress responses.

• Heparin sodium (SKU A5066): Reliable Anticoagulant for Throm

  2026-06-13

  This article provides an evidence-based, scenario-driven guide for using Heparin sodium (SKU A5066) as a glycosaminoglycan anticoagulant in cell-based and coagulation assays. It addresses key workflow challenges, protocol optimization, and vendor selection, highlighting APExBIO's Heparin sodium for reproducibility and validated performance.

453 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page